Hypothesis

The preferential accumulation of 4‑hydroxynonenal (HNE) and malondialdehyde (MDA) adducts on specific mitochondrial proteins (e.g., NDUFS1, SDHA, ATP synthase) during aging is not merely a function of global PUFA peroxidation but is driven by the enrichment of particular cardiolipin (CL) species in microdomains that bring peroxidation‑prone fatty acids into close proximity with those proteins. Age‑associated decline in the phospholipid‑remodeling enzyme tafazzin (TAZ) shifts CL composition toward tetralinoleoyl‑cardiolipin (L4‑CL), which both increases susceptibility to peroxidation and stabilizes protein‑CL interactions that facilitate adduct formation on nearby residues.

Mechanistic Rationale

1. CL microdomains as reaction chambers – CL’s unique conical shape promotes tight packing within the inner mitochondrial membrane, creating nanoscopic domains where polyunsaturated fatty acids (PUFAs) are concentrated. L4‑CL, containing four linoleic acid chains, provides the highest density of bis‑allylic positions, accelerating lipid‑alkoxy‑radical formation and subsequent HNE/MDA generation (see lipid peroxidation mechanism)【5】.
2. Protein‑CL affinity directs adduct targeting – Respiratory proteins such as NDUFS1 and SDHA contain conserved CL‑binding motifs (e.g., basic patches and hydrophobic grooves). Structural studies show that these motifs preferentially interact with L4‑CL over other CL species, positioning the proteins within peroxidation hotspots【1】. Consequently, adduct formation occurs preferentially on residues that are both catalytically critical and situated at the protein‑CL interface (Cys, His, Lys).
3. TAZ decline remodels CL landscape – With age, TAZ activity diminishes, leading to accumulation of immature monolysocardiolipin and a relative increase in L4‑CL due to impaired acyl‑chain exchange【4】. This shift amplifies both peroxidase susceptibility and protein‑CL binding, creating a feed‑forward loop that explains why certain proteins show disproportionate adduct increases (e.g., 8‑fold for NDUFS1, 82 % for SDHA) despite comparable PUFA exposure.
4. Feedback to ROS production – HNE/MDA adduction impairs electron transfer, increasing electron leak and superoxide generation. Elevated ROS further fuels lipid peroxidation, reinforcing the L4‑CL‑driven adduct cycle and contributing to the bioenergetic decline and senescence observed in aging mitochondria【3】.

Testable Predictions

• Prediction 1: In mitochondria isolated from young vs. old tissues, lipidomics will reveal a significant increase in the L4‑CL/total‑CL ratio that correlates with the degree of HNE/MDA adduction on NDUFS1, SDHA, and ATP5A (but not on proteins lacking CL‑binding motifs).
• Prediction 2: Overexpression of TAZ (or supplementation with cardiolipin‑remodeling precursors) in aged cells will restore a more juvenile CL species distribution, reduce L4‑CL enrichment, and specifically diminish adduct formation on the CL‑bound respiratory proteins without altering overall mitochondrial PUFA content.
• Prediction 3: Perturbing the CL‑binding site of NDUFS1 (e.g., mutagenesis of basic residues) will attenuate HNE adduction even when L4‑CL levels are high, demonstrating that protein‑CL interaction is necessary for preferential targeting.
• Prediction 4: Pharmacological inhibition of ALCAT1 will lower total HNE/MDA adducts, but the greatest relative reduction will be observed on proteins with strong CL‑binding affinity; proteins with weak CL interaction will show smaller changes, indicating that ALCAT1’s effect is mediated through CL‑dependent peroxidation hotspots.

Experimental Approach

1. Lipidomics & Immunoprecipitation – Quantify CL species (LC‑MS/MS) and perform immunoprecipitation of NDUFS1, SDHA, ATP5A from young and old mouse liver/heart mitochondria. Probe precipitates for HNE/MDA adducts using dot‑blot or ELISA.
2. Genetic Manipulation – Use AAV‑mediated TAZ overexpression or CRISPR‑knockin of CL‑binding‑deficient mutants in aged mice; assess adduct levels, respiratory function (Seahorse), and senescence markers (p16, SA‑β‑gal).
3. Pharmacological Intervention – Treat aged cells with ALCAT1 inhibitor (e.g., Maestro‑01) ± exogenous L4‑CL liposomes; measure adduct specificity and ROS production.
4. Computational Modeling – Run molecular dynamics simulations of L4‑CL‑containing membrane patches with wild‑type vs. mutant protein domains to predict encounter frequencies of peroxidation‑prone lipids with target residues.

Falsifiability

If L4‑CL enrichment does not correlate with adduct patterns, or if restoring youthful CL composition fails to reduce adducts on CL‑bound proteins while global PUFA levels remain unchanged, the hypothesis would be refuted. Likewise, if mutating CL‑binding sites does not protect proteins from adduction despite high L4‑CL, the proposed mechanism of microdomain‑driven targeting would be invalid.

Implications

Confirming this model would shift the therapeutic focus from global lipid peroxidation scavenging to precise remodeling of cardiolipin species or disruption of pathogenic protein‑CL interactions. Such strategies could preserve respiratory chain function more efficiently, mitigating age‑related bioenergetic collapse and senescence.